tiprankstipranks
TG Therapeutics (TGTX)
NASDAQ:TGTX
Holding TGTX?
Track your performance easily

TG Therapeutics (TGTX) Financial Statements

1,782 Followers

TG Therapeutics Financial Overview

TG Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.106; its P/E ratio is -288.10; TG Therapeutics is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $0.09. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 83.88M$ 73.47M$ 63.47M$ 43.97M$ 165.81M
Gross Profit$ 74.54M$ 65.16M$ 58.03M$ 36.12M$ 162.31M
EBIT$ 4.27M$ 6.55M$ -8.39M$ -11.60M$ 117.64M
EBITDA$ 5.24M$ 7.76M$ -8.31M$ -11.50M$ 117.77M
Net Income Common Stockholders$ 3.88M$ 6.88M$ -10.71M$ -14.42M$ 113.93M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 341.04M$ 217.25M$ 209.78M$ 217.51M$ 229.16M
Total Assets$ 586.01M$ 401.21M$ 373.32M$ 329.59M$ 331.07M
Total Debt$ 253.81M$ 112.54M$ 111.67M$ 110.80M$ 109.91M
Net Debt$ -87.23M$ -104.71M$ -98.12M$ -106.71M$ -119.25M
Total Liabilities$ 393.86M$ 223.64M$ 213.21M$ 169.09M$ 166.30M
Stockholders Equity$ 192.16M$ 177.57M$ 160.11M$ 160.50M$ 164.77M
Cash Flow-
Free Cash Flow$ -12.23M$ 5.54M$ -8.21M$ -13.21M$ 83.70M
Operating Cash Flow$ -12.21M$ 5.54M$ -8.21M$ -13.21M$ 83.70M
Investing Cash Flow$ -9.33M$ 1.76M$ -9.26M$ -44.76M$ -30.23M
Financing Cash Flow$ 134.45M$ 135.00K$ 10.00K$ -1.00K$ 421.00K
Currency in USD

TG Therapeutics Earnings and Revenue History

TG Therapeutics Debt to Assets

TG Therapeutics Cash Flow

TG Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis